(Q44830653)

6 December 2017

title

Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1. (English)

1 reference

6 December 2017

4

1 reference

6 December 2017

K Van Laere

1

1 reference

6 December 2017

L De Ceuninck

2

1 reference

6 December 2017

R Dom

3

1 reference

6 December 2017

H Vanbilloen

5

1 reference

6 December 2017

J Cleynhens

6

1 reference

6 December 2017

P Dupont

7

1 reference

6 December 2017

G Bormans

8

1 reference

6 December 2017

A Verbruggen

9

1 reference

6 December 2017

L Mortelmans

10

1 reference

6 December 2017

publication date

3 April 2004

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

6 December 2017

published in

1 reference

6 December 2017

volume

31

1 reference

6 December 2017

issue

8

1 reference

6 December 2017

page(s)

1119-1127

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-004-1480-6

6 December 2017

exact match

0 references

cites work

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents

1 reference

12 December 2020

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

1 reference

12 December 2020

Neuroleptics and dopamine transporters.

1 reference

12 December 2020

Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent

1 reference

12 December 2020

Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

1 reference

12 December 2020

Radiopharmaceuticals for single-photon emission computed tomography brain imaging

1 reference

12 December 2020

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

12 December 2020

99mTc-M-TRODAT is not superior to (99m)Tc-TRODAT-1 for the diagnosis of Parkinson's disease

1 reference

12 December 2020

A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group

1 reference

12 December 2020

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo

1 reference

12 December 2020

Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems

1 reference

12 December 2020

Development of technetium-99m-based CNS receptor ligands: have there been any advances?

1 reference

12 December 2020

Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.

1 reference

12 December 2020

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

1 reference

12 December 2020

Analysis of clinical brain SPECT data based on anatomic standardization and reference to normal data: an ROC-based comparison of visual, semiquantitative, and voxel-based methods.

1 reference

12 December 2020

Diagnostic criteria for Parkinson disease

1 reference

12 December 2020

A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Imaging end points for monitoring neuroprotection in Parkinson's disease.

1 reference

12 December 2020

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

12 December 2020

Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent.

1 reference

12 December 2020

Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers

1 reference

12 December 2020

The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease.

1 reference

12 December 2020

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

1 reference

12 December 2020

Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging

1 reference

12 December 2020

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

1 reference

12 December 2020

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

1 reference

12 December 2020

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study

1 reference

12 December 2020

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

1 reference

12 December 2020

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

1 reference

12 December 2020

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

1 reference

12 December 2020

Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.

1 reference

12 December 2020

[123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease

1 reference

12 December 2020

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET.

1 reference

12 December 2020

Transfer of normal 99mTc-ECD brain SPET databases between different gamma cameras

1 reference

12 December 2020

The evolution of diagnosis in early Parkinson disease. Parkinson Study Group

1 reference

12 December 2020

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

1 reference

12 December 2020

[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease

1 reference

12 December 2020

One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.

1 reference

12 December 2020

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters

1 reference

12 December 2020

10.1007/S00259-004-1480-6

Identifiers

DOI

1 reference

6 December 2017

1 reference